Researchers looked at data for 18,318 physicians who received opioid use disorder medication promotions, totaling $9.6 million during the study period.
Medicaid expansion is associated with a reduction in total opioid overdose deaths and with increases in methadone-related mortality.
Patients perception of poor sleep differ from EEG-reported results.
Coprescription of benzodiazepines and opioid agonist treatment (OAT) is associated with an increased risk for drug-related poisoning (DRP) mortality in opioid-dependent individuals.
Prescription opioid use among teens and young adults is higher than expected, with most obtaining the drugs from friends and family.
Traditionally, suicide and overdose prevention in opioid use disorder involve stratifying risk based on certain demographic and clinical factors.
Overall, of 333 adult patients, 15.9% of patients reported opioid misuse, 17.1% were positive for PTSD, and 52.6% were positive for depression.
Mind-body therapies were linked with small declines in opioid dose, a promising finding in light of concerns surrounding the scale of opioid prescriptions in the United States.
The adjusted rate of opioid use increased nearly 4-fold (adjusted odds ratio, 4.18; 95% CI, 1.76-9.96), from 4.7% among new immigrants to 14.8% among those who had been in this country for 15 years or more.
Overdose resulting from carfentanil ingestion may require larger doses of naloxone for successful resuscitation, according to a new case report.